Australia’s Future Fund posted a 12.2% return for 2024 as the sovereign wealth fund reaped the benefit of increasing positions in international equities.
Farapulse, Boston Scientific’s pulsed field ablation product, fueled year-over-year growth of nearly 171% in the fourth ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback